Pure Biologics webinar - year summary and project updates

Webinar with the management.

News

Inquiries

Pure Biologics teams up with Twist Bioscience

15 April

2021

Pure Biologics teams up with Twist Bioscience

Pure Biologics joins efforts with Twist Bioscience to expand the capabilities of the phage display technology used in Pure Biologics' portfolio of immuno-oncology projects.

Project PB002 – preclinical research partner selected

19 March

2021

Project PB002 – preclinical research partner selected

Pure Biologics has selected a partner to lead the first panel of preclinical studies in the PB002 aptamer project

W poszukiwaniu nowych leków i przełomowych terapii – article in “Rzeczpospolita”

3 March

2021

W poszukiwaniu nowych leków i przełomowych terapii – article in “Rzeczpospolita”

An article presenting global trends in pharmaceutical R&D and how Polish companies fit into them.

European patent for modified aptamers (PB012 PureApta)

9 February

2021

European patent for modified aptamers (PB012 PureApta)

The European Patent Office issued a decision on granting a European patent for PureApta elements.

Pure Biologics’ publication in the Journal of Biomedical Science

28 January

2021

Pure Biologics’ publication in the Journal of Biomedical Science

Klaus, T., Deshmukh, S. pH-responsive antibodies for therapeutic applications. J Biomed Sci 28, 11 (2021)

9 October

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

17 June

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

10 April

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

25 January

2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

21 January

2020